{"text": ["UPDATE", "1-High-cost", "Gilead", "cell", "therapy", "proves", "durable", "for", "some", "lymphoma", "patients"], "created_at": "2018-12-03 18:32:16"}
{"text": ["Novartis", "SMA", "treatment", "could", "get", "FDA", "approval", "in", "May"], "created_at": "2018-12-03 06:46:31"}
{"text": ["Novartis:", "FDA", "Accepted", "BLA", "For", "SMA", "Type", "1", "Gene", "Replacement", "Therapy", "ZOLGENSMA"], "created_at": "2018-12-03 01:48:00"}
{"text": ["Novartis:", "FDA", "Accepted", "BLA", "For", "SMA", "Type", "1", "Gene", "Replacement", "Therapy", "ZOLGENSMA"], "created_at": "2018-12-03 01:48:00"}
